Mainz Biomed NV banner

Mainz Biomed NV
NASDAQ:QUCY

Watchlist Manager
Mainz Biomed NV Logo
Mainz Biomed NV
NASDAQ:QUCY
Watchlist
Price: 0.4985 USD 3.9% Market Closed
Market Cap: $4.5m

Wall Street
Price Targets

QUCY Price Targets Summary
Mainz Biomed NV

There are no price targets for QUCY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Mainz Biomed NV Competitors:
Price Targets
FLB
Fluidigm Corp
63% Upside
VINP
Vinci Partners Investments Ltd
38% Upside
CFFN
Capitol Federal Financial Inc
11% Upside
TCPC
BlackRock TCP Capital Corp
84% Upside
TENB
Tenable Holdings Inc
66% Upside

Revenue
Forecast

16% / Year
Past Growth
142% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
16% / Year
Past Growth
142% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

For the last 4 years the compound annual growth rate for Mainz Biomed NV's revenue is 16%. The projected CAGR for the next 4 years is 142%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is QUCY's stock price target?
Not Available

QUCY doesn't have any price targets made by Wall Street professionals.

What is Mainz Biomed NV's Revenue forecast?
Projected CAGR
142%

For the last 4 years the compound annual growth rate for Mainz Biomed NV's revenue is 16%. The projected CAGR for the next 4 years is 142%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett